WORLD MUSCLE SOCIETY
The activities of WMS are open to all professionals working in the neuromuscular field. It is a multidisciplinary Society reflecting in particular the different disciplines involved in the study of neuromuscular disorders and the management of patients with these disorders.
Financial health, per its FY2024 accounts
The accounts state that the charity incurred a net expenditure of £109,379 for the year, resulting in a decrease in total funds from £1,065,692 to £956,313. The trustees report that free reserves of £937,311 are below their stated policy target of £1,000,000, though they consider these sufficient to continue as a going concern.
What the accounts disclose
“The trustees have a policy of holding £1,000,000 reserves.” — page 5
“At the year end, £177,479 is due back to WMS Congress Limited, the charity's subsidiary and is included in creditors (2023: £nil). There were no other related party transactions in either year.” — page 18
Structured financials (annual return, FY ending 31/12/2022)
Trustees
- A/ Professor Gianina Ravenscroft
- Dr GISELE BONNE
- Dr Giorgia Coratti
- Dr Lindsay Alfano
- Dr Tamara Dangouloff
- Dr Teresinha Evangelista
- Dr Werner Stenzel
- PROFESSOR ICHIZO NISHINO
- PROFESSOR Laurent Servais
- PROFESSOR VOLKER STRAUB
- Professor Carsten Bonnemann
- Professor Edoardo Malfatti
- Professor Giovanni Baranello
- Professor Jordi Diaz-Manera
- Professor Nicol Voermans
- Professor, Dr Jorge Alfredo Bevilacqua
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £414k | £523k |
| 31/12/2023 | £140k | £389k |
| 31/12/2022 | £579k | £192k |
| 31/12/2021 | £515k | £117k |
| 31/12/2020 | £124k | £128k |
Common questions
Is WORLD MUSCLE SOCIETY financially healthy?
Per its FY2024 accounts: The accounts state that the charity incurred a net expenditure of £109,379 for the year, resulting in a decrease in total funds from £1,065,692 to £956,313. The trustees report that free reserves of £937,311 are below their stated policy target of £1,000,000, though they consider these sufficient to continue as a going concern. Its FY2024 accounts were independently examined.